siRNA therapy lowers triglycerides in clients with rare problem

.INVESTIGATION FEATURE.19 September 2024.

Plozasiran lessened triglyceride amounts through 80% as well as decreased the risk of pancreatitis in patients along with persistent chylomicronemia, with or even without a hereditary medical diagnosis.